BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17008536)

  • 21. Childhood acute myeloid leukemia.
    Rubnitz JE
    Curr Treat Options Oncol; 2008 Feb; 9(1):95-105. PubMed ID: 18506629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.
    Márkász L; Hajas G; Kiss A; Lontay B; Rajnavölgyi E; Erdodi F; Oláh E
    Pathol Oncol Res; 2008 Sep; 14(3):285-92. PubMed ID: 18493867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
    Kang KW; Kim DS; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim BS; Park Y
    Leuk Res; 2017 Jun; 57():1-8. PubMed ID: 28231491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.
    Alonzo TA; Kobrinsky NL; Aledo A; Lange BJ; Buxton AB; Woods WG
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):627-35. PubMed ID: 12439034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.
    Inaba H; Cao X; Pounds S; Pui CH; Rubnitz JE; Ribeiro RC; Razzouk BI
    Cancer; 2011 Mar; 117(6):1313-20. PubMed ID: 21381017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.
    Lehrnbecher T; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Creutzig U
    Blood; 2007 Feb; 109(3):936-43. PubMed ID: 17008536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
    Feng X; Lan H; Ruan Y; Li C
    Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.
    Gurion R; Belnik-Plitman Y; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008238. PubMed ID: 21901718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid growth factors in acute myeloid leukemia: systematic review of randomized controlled trials.
    Heuser M; Zapf A; Morgan M; Krauter J; Ganser A
    Ann Hematol; 2011 Mar; 90(3):273-81. PubMed ID: 20838825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
    Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
    Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of granulocyte colony-stimulating factors on survival parameters in pediatric patients with acute lymphoblastic leukemia: A retrospective study.
    Tekgunduz SA; Aycicek A; Bayram C; Uysalol EP; Akici F; Ozdemir GN
    Transfus Apher Sci; 2022 Feb; 61(1):103366. PubMed ID: 35120829
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.